| 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 248,1 k € | ||||
| Gross margin | 2,1 M € | +60758.0% | -3,5 k € | -102.9% | 121,5 k € | +120.2% | -602,9 k € | |
| EBITDA | -4,6 M € | -60.7% | -2,9 M € | +1.7% | -2,9 M € | -32.8% | -2,2 M € | |
| Operating profit | -5,0 M € | -60.5% | -3,1 M € | +0.4% | -3,1 M € | -41.3% | -2,2 M € | |
| Profit/loss | -5,1 M € | -57.9% | -3,2 M € | -0.7% | -3,2 M € | -40.9% | -2,3 M € | |
| Equity | 44,6 M € | +29.0% | 34,6 M € | +345.3% | 7,8 M € | -29.1% | 10,9 M € | |
| Total assets | 53,0 M € | +27.4% | 41,6 M € | +194.9% | 14,1 M € | -9.4% | 15,6 M € | |
| Cash | 517,4 k € | -62.4% | 1,4 M € | -56.0% | 3,1 M € | -60.3% | 7,9 M € | |
| Debts | 8,5 M € | +19.7% | 7,1 M € | +11.2% | 6,4 M € | +38.5% | 4,6 M € | |
| Staff | 16,3 | 15,3 | 14,7 | — | ||||
Private limited company · Gembloux · incorporated on 06/10/2021 · 16,3 ETP
Private limited company loss-making in the latest fiscal year. Cash position declining (-62.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Full-Life Technology Europe is a Private limited company incorporated in 2021. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Gembloux. It employs on average 16,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette